XBiotech Inc

XBIT

Get informed when a big investor buys or sells

Market Cap$70.43M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
XBiotech Inc	-1.8	-	-30%	-	-

$4.12

Current Fair Value

76.7% upside

Undervalued by 76.7% based on the discounted cash flow analysis.

Share Statistics

Market cap	$70.43 Million
Enterprise Value	$-44,925,341.00
Dividend Yield	$- (-)
Earnings per Share	$-1.49
Beta	0.84
Outstanding Shares	30,487,731

Return

Return on Equity	-29.75%
Return on Assets	-28.72%
Return on Invested Capital	-31.91%

Valuation & Multiples

P/E Ratio	-1.75
PEG	3.55
Price to Sales	-
Price to Book Ratio	0.58
Enterprise Value to Revenue	-
Enterprise Value to EBIT	1.03
Enterprise Value to Net Income	1
Total Debt to Enterprise	0
Debt to Equity	0

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

May 14, 2026

EPS Estimate

$0.03

Average shareholder expectation

Revenue Estimate

$7.00 M

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.00000%
Total Calls	21,100▲ 14.67%
Total Puts	-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	6.54%▼ 0.99%
Total Invested	$4.68M▼ 14.62%
Investors Holding	38▼ 2.00%

ESG Score